Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months

Am Rev Respir Dis. 1977 Nov;116(5):807-20. doi: 10.1164/arrd.1977.116.5.807.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Antibodies
  • Clinical Trials as Topic
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Female
  • Humans
  • Isoniazid / administration & dosage*
  • Isoniazid / adverse effects
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis / drug effects
  • Rifampin / administration & dosage*
  • Rifampin / adverse effects
  • Rifampin / immunology
  • Singapore
  • Thrombocytopenia / chemically induced
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Antibodies
  • Isoniazid
  • Rifampin